These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pharmacokinetics of graded oral doses of sulindac in man. Mattila J; Mäntylä R; Vuorela A; Lamminsivu U; Männistö P Arzneimittelforschung; 1984; 34(2):226-9. PubMed ID: 6539116 [TBL] [Abstract][Full Text] [Related]
6. Effect of dimethyl sulfoxide on sulindac disposition in rats. Swanson BN; Mojaverian P; Boppana VK; Dudash MR Drug Metab Dispos; 1981; 9(6):499-502. PubMed ID: 6120805 [TBL] [Abstract][Full Text] [Related]
7. Sulindac: therapeutic implications of the prodrug/pharmacophore equilibrium. Duggan DE Drug Metab Rev; 1981; 12(2):325-37. PubMed ID: 7040018 [TBL] [Abstract][Full Text] [Related]
8. Biliary secretion of sulindac and metabolites in man. Dobrinska MR; Furst DE; Spiegel T; Vincek WC; Tompkins R; Duggan DE; Davies RO; Paulus HE Biopharm Drug Dispos; 1983; 4(4):347-58. PubMed ID: 6661513 [TBL] [Abstract][Full Text] [Related]
9. Sulindac disposition when given once and twice daily. Swanson BN; Boppana VK; Vlasses PH; Holmes GI; Monsell K; Ferguson RK Clin Pharmacol Ther; 1982 Sep; 32(3):397-403. PubMed ID: 7049504 [TBL] [Abstract][Full Text] [Related]
10. Kinetics of the tissue distributions of sulindac and metabolites. Relevance to sites and rates of bioactivation. Duggan DE; Hooke KF; Hwang SS Drug Metab Dispos; 1980; 8(4):241-6. PubMed ID: 6105058 [TBL] [Abstract][Full Text] [Related]
11. A kinetic study of sulindac in the elderly. Bayley N; Warne RW; Moulds RF; Bury RW Aust N Z J Med; 1987 Feb; 17(1):39-42. PubMed ID: 3476045 [TBL] [Abstract][Full Text] [Related]
12. Sulindac: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases. Brogden RN; Heel RC; Speight TM; Avery GS Drugs; 1978 Aug; 16(2):97-114. PubMed ID: 352667 [No Abstract] [Full Text] [Related]
13. Effect of uremia and anephric state on the pharmacokinetics of sulindac and its metabolites in rats. I. An application of pharmacokinetic model for reversible metabolism. Lin JH; Yeh KC; Duggan DE Drug Metab Dispos; 1985; 13(5):602-7. PubMed ID: 2865111 [TBL] [Abstract][Full Text] [Related]
14. In vitro metabolism of sulindac and sulindac sulfide: enzymatic formation of sulfoxide and sulfone. Kitamura S; Tatsumi K Jpn J Pharmacol; 1982 Oct; 32(5):833-8. PubMed ID: 7176218 [TBL] [Abstract][Full Text] [Related]
16. Nonsteroidal anti-inflammatory effect of sulindac sulfoxide and sulfide on gastric mucosa. Graham DY; Smith JL; Holmes GI; Davies RO Clin Pharmacol Ther; 1985 Jul; 38(1):65-70. PubMed ID: 3874038 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of sulindac metabolism by dimethyl sulfoxide in the rat. Swanson BN; Mojaverian P; Boppana VK J Toxicol Environ Health; 1983; 12(2-3):213-22. PubMed ID: 6655731 [TBL] [Abstract][Full Text] [Related]
18. The effects of sulindac and its metabolites on acute stress-induced gastric ulcers in rats. Glavin GB; Sitar DS Toxicol Appl Pharmacol; 1986 Apr; 83(2):386-9. PubMed ID: 3961821 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in mouse lung explants. Bouchard L; Castonguay A Drug Metab Dispos; 1993; 21(2):293-8. PubMed ID: 8097699 [TBL] [Abstract][Full Text] [Related]
20. Effects of age and disease on the pharmacokinetics and pharmacodynamics of sulindac. Sitar DS; Owen JA; MacDougall B; Hunter T; Mitenko PA Clin Pharmacol Ther; 1985 Aug; 38(2):228-34. PubMed ID: 4017423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]